The Effects of High-Intensity Exercise on Biological Age
1 other identifier
interventional
35
1 country
1
Brief Summary
The purpose of this graduate student research study is to determine if a high-intensity exercise program can slow or reverse biological (transcriptomic) aging and shed light on the underlying transcriptomic pathways involved.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 29, 2021
CompletedStudy Start
First participant enrolled
November 29, 2021
CompletedFirst Posted
Study publicly available on registry
December 14, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 28, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 28, 2022
CompletedJune 30, 2022
June 1, 2022
7 months
November 29, 2021
June 28, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
venipuncture procedure
Participants will have 8ml of blood drawn on two separate occasions by a certified phlebotomist. The first 8 ml (1.62tsp) blood draw will occur at 8am on day 1 of the study protocol. The second 8ml (1.62tsp) blood draw will occur approximately 30 days later. The total blood draw volume will be 16ml or approximately 3.25 teaspoons. The blood draw is to test for the effects of exercise on gene expression and aging.
Change between baseline and 30 days
Secondary Outcomes (2)
Perceived stress scale survey
Change between baseline and 30 days
Pittsburgh Sleep Quality Index
Change between baseline and 30 days
Study Arms (2)
Exercise Group
EXPERIMENTALExercise group participants will perform supervised high intensity exercise three times per week at the LLU department of physical therapy laboratory utilizing treadmills, stationary bicycles, and rowing machines.
Control Group
ACTIVE COMPARATORControl group participants will make no modifications to regular diet or exercise habits for 30 days.
Interventions
Participants will rotate between three exercise machines (randomly assigned rotation order at outset): A Concept C2 rowing machine, a stationary bicycle, and a treadmill. Study participants will use a different machine each day so that they are using each of the three exercise machines once per week. Two treadmills, two bikes, and two rowers are available during each exercise session. Participants will be randomly assigned to one of three machine orders: treadmill-rower-bike, rower-bike-treadmill, or bike-treadmill-rower. We will employ a percent of heart rate protocol as an exercise intensity measure (77-93% of age-adjusted maximum heart rate) rather than a less well-defined maximal effort protocol or rating of perceived exertion scale. For the purposes of this exercise protocol high intensity exercise will be defined as 77-93% of age adjusted maximum heart rate.
There are no modifications to regular diet or exercise habits for 30 days.
Eligibility Criteria
You may qualify if:
- Sex: Both Males and Females
- Age: 40-65 years old
- Physical Fitness: Below average scores on the Self report fitness questionnaire
- Physical Activity: Low as measured by the International Physical Activity Questionnaire
You may not qualify if:
- Prior (within the last 5 years) or current history of cardiovascular disease, stroke, unexplained weight loss, clinical depression, congestive heart failure, cancer, arrythmia, respiratory disease, or other serious medical conditions that would make exercise unsafe or prevent full participation in the exercise protocol.
- Any self-reported significant increase or decrease in activity levels within the past thirty days.
- Current use of the following medications: antibiotics, glucocorticoids, anticoagulants, narcotics, antiepileptic medications, antipsychotics, antidepressants, and hypoglycemic agents.
- Current self-reported pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Loma Linda University
Loma Linda, California, 92350, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gurinder Bains, PhD
Loma Linda University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor School of Allied Health
Study Record Dates
First Submitted
November 29, 2021
First Posted
December 14, 2021
Study Start
November 29, 2021
Primary Completion
June 28, 2022
Study Completion
June 28, 2022
Last Updated
June 30, 2022
Record last verified: 2022-06